journal article·2025-09-26

Anticancer Therapy Using FePt Nanoparticles Combined with Nanosecond Pulsed Electric Fields

Shen Hu, Yan Zhu, Pu Cheng, Guoliang Dai, Ligui Jin, Qingqing Wang, Xinhua Chen, Chongyang Cai

ACS Applied Nano Materials· Volume 8· Issue 38
Publisher page

Abstract

Nanosecond pulsed electric fields (nsPEFs) are an emerging local tumor treatment based on physical fields, that can destroy tumor core cells using ultrashort, high-intensity electric pulses. Despite their promise, technical and safety constraints can result in incomplete ablation at tumor margins during clinical procedures, allowing residual cancer cells to persist and metastasize. This study introduces an innovative strategy that combines nsPEFs with FePt nanoparticles (NPs) based on modern physics. Both in vitro and in vivo experiments reveal that this integrated approach enhances imaging precision and delivers synergistic antitumor effects. In orthotopic pancreatic cancer models, nsPEFs effectively eradicate the tumor core, overcoming the limitation of NPs alone that are unable to completely eradicate tumor cells. Although some peripheral cancer cells may survive and migrate post-electric field treatment, systemically administered NPs rapidly target tumor sites, selectively targeting and destroying these escaped cells. This strategy addresses the challenges of metastasis and recurrence associated with nsPEF monotherapy. Findings show that the combined treatment significantly suppresses tumor progression and improves both survival status and rates in mice. By uniting the complementary strengths of nsPEFs and NPs, this study offers substantial theoretical insight and practical value for developing advanced combination cancer therapies with strong clinical translation potential.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Microbial Inactivation Methods · Molecular Communication and Nanonetworks · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Obstetrics

The Second Affiliated Hospital of Zhejiang University School of Medicine

Department of Epidemiology

The Harvard T.H. Chan School of Public Health

Department of Pulmonary and Critical Care Medicine, Shulan (Hangzhou) Hospital, Shulan International Medical College

Zhejiang Shuren University

Department of Gynecology

Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital

Zhejiang University

Department of Urology

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

Funding

Natural Science Foundation of Zhejiang Province · Health Bureau of Zhejiang Province/General Program · Zhejiang Traditional Chinese Medicine Science and Technology Program

References (44)

Show source-provided references
1. 10.1021/acsanm.5c0076210.1021/acsanm.5c00762 ↗
2. 10.1213/ANE.0b013e3181de0ab610.1213/ANE.0b013e3181de0ab6 ↗
3. 10.1038/s41575-023-00840-w10.1038/s41575-023-00840-w ↗
4. 10.1016/j.trecan.2018.04.00110.1016/j.trecan.2018.04.001 ↗
5. 10.1038/s41571-020-0363-510.1038/s41571-020-0363-5 ↗
6. 10.1038/s41575-023-00856-210.1038/s41575-023-00856-2 ↗
7. 10.1038/s41571-023-00746-110.1038/s41571-023-00746-1 ↗
8. 10.1002/cncr.3085610.1002/cncr.30856 ↗
9. 10.1021/acsanm.4c0473310.1021/acsanm.4c04733 ↗
10. 10.1146/annurev-pathmechdis-031621-02460010.1146/annurev-pathmechdis-031621-024600 ↗
11. 10.1016/j.ccell.2020.08.00410.1016/j.ccell.2020.08.004 ↗
12. 10.1186/s13045-024-01561-610.1186/s13045-024-01561-6 ↗
13. 10.1126/science.aaw987210.1126/science.aaw9872 ↗
14. 10.1038/nature1976410.1038/nature19764 ↗
15. 10.1038/s41551-017-003910.1038/s41551-017-0039 ↗
16. 10.1038/s41587-023-02060-810.1038/s41587-023-02060-8 ↗
17. 10.1080/02656736.2023.225058610.1080/02656736.2023.2250586 ↗
18. 10.21037/hbsn.2015.11.0310.21037/hbsn.2015.11.03 ↗
19. 10.1186/s12943-023-01798-810.1186/s12943-023-01798-8 ↗
20. 10.1038/s41467-023-42740-210.1038/s41467-023-42740-2 ↗
21. 10.1002/smll.20220216110.1002/smll.202202161 ↗
22. 10.1016/j.bioelechem.2024.10880310.1016/j.bioelechem.2024.108803 ↗
23. 10.1016/j.canlet.2023.21651410.1016/j.canlet.2023.216514 ↗
24. 10.1016/j.compbiomed.2023.10782410.1016/j.compbiomed.2023.107824 ↗
25. 10.1038/s41598-024-51298-y10.1038/s41598-024-51298-y ↗
26. 10.1002/1878-0261.1337210.1002/1878-0261.13372 ↗
27. 10.3390/cancers1507207610.3390/cancers15072076 ↗
28. 10.3390/ijms24191499910.3390/ijms241914999 ↗
29. 10.1038/s41598-023-27605-410.1038/s41598-023-27605-4 ↗
30. 10.1021/acs.jpcb.3c0114810.1021/acs.jpcb.3c01148 ↗
31. 10.1007/s11684-020-0747-z10.1007/s11684-020-0747-z ↗
32. 10.1016/j.bioelechem.2025.10901610.1016/j.bioelechem.2025.109016 ↗
33. 10.1016/j.bioelechem.2024.10880310.1016/j.bioelechem.2024.108803 ↗
34. 10.1016/j.cell.2021.09.02210.1016/j.cell.2021.09.022 ↗
35. 10.1088/1361-6463/abdd6910.1088/1361-6463/abdd69 ↗
36. 10.1039/D3TB02145A10.1039/D3TB02145A ↗
37. 10.1021/acsanm.5c0262110.1021/acsanm.5c02621 ↗
38. 10.1016/j.actbio.2022.08.02610.1016/j.actbio.2022.08.026 ↗
39. 10.1002/adma.20210047210.1002/adma.202100472 ↗
40. 10.1186/s12951-022-01482-x10.1186/s12951-022-01482-x ↗
41. 10.2147/IJN.S45360110.2147/IJN.S453601 ↗
42. 10.1039/C6NR09122A10.1039/C6NR09122A ↗
43. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
44. 10.1002/adma.20230524910.1002/adma.202305249 ↗